Back to Newsroom

Novavax to Present at the Wedbush PacGrow Healthcare Conference

GAITHERSBURG, Md., Aug. 05, 2015 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the Wedbush PacGrow Healthcare Conference.

Click here to read more